<DOC>
	<DOCNO>NCT03028311</DOCNO>
	<brief_summary>The goal clinical research study learn safety give SIR-Spheres treatment patient liver cancer session rather 2 session , standard care .</brief_summary>
	<brief_title>Feasibility Single Session In-Room Yttrium-90 Radioembolization Diagnostic Angiography Treatment</brief_title>
	<detailed_description>If participant agrees take part study , standard-of-care test procedure part plan SIR-Spheres treatment . The SIR-Spheres treatment delivers radiation directly liver catheter place artery groin . A catheter sterile flexible tube place large artery participant local anesthesia mildly sedate . Participant 's doctor explain procedure detail . If participant one first 2 participant enrol study , treatment 2 session within 2-4 week , standard care . During participant 's first session , extra 10 minute add standard image research purpose . Each visit take 6 hour complete . Participant 2 hour standard care test image ask stay hospital 1-2 hour procedure recover anesthesia . The procedure take 2 1/2 hour complete . If participant enrolls first 2 participant , treatment 1 session . The visit take 8 hour complete . During visit , participant 5 hour standard care test image . Participant ask remain hospital 1-2 hour procedure recover anesthesia . The procedure take 2½ 3½ hour complete . Participant sign separate consent test , procedure , SIR-Spheres treatment explain procedure risk . The standard care test include blood draw routine testing . Follow-Up : Participant call study staff 1 month SIR-Spheres treatment ask side effect . The phone call last 10 minute . At 3 month 6 month treatment , participant return clinic physical exam . Blood ( 6 tablespoon ) draw routine test . Length Study : Participant study follow-up visit . This investigational study . The SIR-Spheres deliver use FDA approve commercially available method . It investigational learn procedure safely perform single session . Up 12 participant enrol study . All take part MD Anderson .</detailed_description>
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Liver Neoplasms</mesh_term>
	<criteria>1 . Patients 18 year old . 2 . The ability understand sign inform consent . 3 . Any candidate eligible standard care Y90 radioembolization treatment primary metastatic liver tumor . 1 ) Patients great 50 % liver tumor burden .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Malignant neoplasm digestive organ</keyword>
	<keyword>Metastatic liver tumor</keyword>
	<keyword>SIR-Spheres treatment</keyword>
	<keyword>90Y-radioembolization</keyword>
</DOC>